Opus Genetics, Inc.
IRD· Nasdaq
Opus Genetics, Inc.
- Last sale
- Oct 2, 2026 · +1.66%
- Market cap
- $381.87M
- 83.2M shares
- Filings
- 1,031
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $14,196,000 | reported | |
| FY 2024 | 2024-12-31 | $10,992,000 | reported | |
| FY 2023 | 2023-12-31 | $19,049,000 | reported | |
| FY 2022 | 2022-12-31 | $39,850,000 | reported | |
| FY 2021 | 2021-12-31 | $589,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2019 | 2019-12-31 | $3,000,000 | reported | |
| FY 2013 | 2013-12-31 | $0 | reported | |
| FY 2012 | 2012-12-31 | $0 | reported | |
| FY 2011 | 2011-12-31 | $0 | reported | |
| FY 2010 | 2010-12-31 | $0 | reported | |
| FY 2009 | 2009-12-31 | $0 | reported |
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
